Nutex Health Inc.
NUTX
$187.60
$1.760.95%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 210.75M | 216.49M | 151.68M | 267.80M | 243.99M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 210.75M | 216.49M | 151.68M | 267.80M | 243.99M |
| Cost of Revenue | 64.16M | 119.26M | 93.85M | 107.92M | 113.81M |
| Gross Profit | 146.60M | 97.22M | 57.83M | 159.88M | 130.17M |
| SG&A Expenses | 19.56M | 10.47M | -95.28M | 24.51M | 91.25M |
| Depreciation & Amortization | 5.32M | 5.49M | 5.19M | 5.00M | 5.25M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 89.03M | 135.22M | 3.76M | 137.44M | 210.31M |
| Operating Income | 121.72M | 81.27M | 147.92M | 130.37M | 33.68M |
| Income Before Tax | 117.09M | 76.56M | 25.89M | 123.94M | 23.73M |
| Income Tax Expenses | 20.77M | 13.80M | 9.29M | 27.14M | 7.59M |
| Earnings from Continuing Operations | 96.32M | 62.76M | 16.61M | 96.80M | 16.14M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -30.48M | -15.96M | -4.77M | -41.36M | -33.84M |
| Net Income | 65.84M | 46.81M | 11.83M | 55.44M | -17.70M |
| EBIT | 121.72M | 81.27M | 147.92M | 130.37M | 33.68M |
| EBITDA | 127.04M | 86.76M | 153.11M | 135.37M | 38.93M |
| EPS Basic | 9.58 | 6.70 | 1.67 | 8.27 | -2.95 |
| Normalized Basic EPS | 6.22 | 4.56 | 11.96 | 5.39 | -3.17 |
| EPS Diluted | 9.38 | 6.52 | 1.56 | 7.76 | -2.95 |
| Normalized Diluted EPS | 6.08 | 4.44 | 11.96 | 5.03 | -3.17 |
| Average Basic Shares Outstanding | 6.87M | 6.99M | 7.07M | 6.70M | 5.99M |
| Average Diluted Shares Outstanding | 7.02M | 7.18M | 7.07M | 7.18M | 5.99M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |